Although advanced age and presence of comorbidities significantly impact the variation
observed in the clinical symptoms of COVID-19, it has been suggested that genetic variants …

Abstract Coronavirus disease 2019 (COVID-19) caused by a novel coronavirus, severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in considerable …

Host genetic polymorphisms are recognized as a critical determinant of diversity in clinical
symptoms of Coronavirus disease 2019 (COVID-19). Accordingly, this study aimed to …

Abstract Coronavirus disease 2019 (COVID‐19), caused by a highly pathogenic emerging
virus, is called severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Knowledge …

The world is presently in crisis facing an outbreak of a health‐threatening microorganism
known as COVID‐19, responsible for causing uncommon viral pneumonia in humans. The …

The pandemic burden caused by the SARS-CoV-2 coronavirus constitutes a global public
health emergency. Increasing understanding about predisposing factors to infection and …

Viral infections activate the innate immune response and the secretion of inflammatory
cytokines. They also alter oxidative stress markers, which potentially can have an …

Objective: to screen putative associations between liver markers and proinflammatory-
related features concerning infectious morbidity and fatal outcomes in COVID-19 patients …

Background Genome-wide association studies have identified numerous human host
genetic risk variants that play a substantial role in the host immune response to SARS-CoV …

Background The aim of this study was to evaluate the impact of the COVID-19 pandemic on
trajectories in cardiometabolic health, physical activity, and functioning among US older …